Preclinical evaluation of theranostic strategy using nanoplatform and transferrin to target hyperactivity of cMYC in the context of non-small cell lung cancer
Autor: | Aubert, S. Martin, Richard, M., Kereselidze, D., Evans, M., Kuhnast, B., Porcel, E., Truillet, C. |
---|---|
Zdroj: | In Médecine Nucléaire March 2023 47(2):51-51 |
Databáze: | ScienceDirect |
Externí odkaz: |